Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ambulation for Latency During Expectant Management of PPROM: A Randomized Controlled Trial (AMBLE)

NCT04230967 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT04230967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04230967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ambulation for Latency During Expectant Management of PPROM: A Randomized Controlled Trial (AMBLE)
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2020
Completion date
March 30, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy complications, pregnancy, high risk, preterm premature rupture of the membranes